Individualized treatment for acute Achilles tendon rupture based on the Copenhagen Achilles Rupture Treatment Algorithm (CARTA): a study protocol for a multicenter randomized controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Individualized treatment for acute Achilles tendon rupture based on the Copenhagen Achilles Rupture Treatment Algorithm (CARTA) : a study protocol for a multicenter randomized controlled trial. / Hansen, Maria Swennergren; Vestermark, Marianne Toft; Hölmich, Per; Kristensen, Morten Tange; Barfod, Kristoffer Weisskirchner.
In: Trials, Vol. 21, 399, 2020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Individualized treatment for acute Achilles tendon rupture based on the Copenhagen Achilles Rupture Treatment Algorithm (CARTA)
T2 - a study protocol for a multicenter randomized controlled trial
AU - Hansen, Maria Swennergren
AU - Vestermark, Marianne Toft
AU - Hölmich, Per
AU - Kristensen, Morten Tange
AU - Barfod, Kristoffer Weisskirchner
PY - 2020
Y1 - 2020
N2 - BACKGROUND: An individualized treatment algorithm (Copenhagen Achilles Rupture Treatment Algorithm (CARTA)) based on the ultrasonographic appearance of an acute Achilles tendon rupture has been developed aiming to select the correct patients for operative and non-operative treatment. The objective of this study is to investigate if this individualized treatment algorithm gives a better functional outcome than treating all patients either operatively or non-operatively per default.METHODS/DESIGN: This study is conducted as a multicenter, three-armed randomized controlled trial. Participants are included from four hospitals in Denmark and randomized 1:1:1 to one of three parallel groups: 1) Intervention group-participants are treated according to an individualized treatment algorithm; 2) Control group A-participants are treated non-operatively; 3) Control group B-participants are treated operatively. The individualized treatment algorithm for the intervention group is based on an ultrasonographic examination; tendon overlap and elongation below 7% is to be treated non-operatively, while no tendon overlap and/or elongation above 7% will be treated operatively. Over a period of 3 years, 300 participants will be included. The primary outcome is the heel-rise work test at 12 months post-injury. Secondary outcomes are tendon elongation, the Achilles tendon Total Rupture Score (ATRS), the rate of re-ruptures, and other complications. The primary analysis will be conducted as an intention-to-treat analysis.DISCUSSION: This trial will indicate if treatment of acute Achilles tendon rupture can be individualized based on elongation and tendon overlap. It is hypothesized that different patients will benefit from different treatments instead of offering all the same treatment.TRIAL REGISTRATION: ClinicalTrials.gov, NCT03525964. Registered 16 May 2018.
AB - BACKGROUND: An individualized treatment algorithm (Copenhagen Achilles Rupture Treatment Algorithm (CARTA)) based on the ultrasonographic appearance of an acute Achilles tendon rupture has been developed aiming to select the correct patients for operative and non-operative treatment. The objective of this study is to investigate if this individualized treatment algorithm gives a better functional outcome than treating all patients either operatively or non-operatively per default.METHODS/DESIGN: This study is conducted as a multicenter, three-armed randomized controlled trial. Participants are included from four hospitals in Denmark and randomized 1:1:1 to one of three parallel groups: 1) Intervention group-participants are treated according to an individualized treatment algorithm; 2) Control group A-participants are treated non-operatively; 3) Control group B-participants are treated operatively. The individualized treatment algorithm for the intervention group is based on an ultrasonographic examination; tendon overlap and elongation below 7% is to be treated non-operatively, while no tendon overlap and/or elongation above 7% will be treated operatively. Over a period of 3 years, 300 participants will be included. The primary outcome is the heel-rise work test at 12 months post-injury. Secondary outcomes are tendon elongation, the Achilles tendon Total Rupture Score (ATRS), the rate of re-ruptures, and other complications. The primary analysis will be conducted as an intention-to-treat analysis.DISCUSSION: This trial will indicate if treatment of acute Achilles tendon rupture can be individualized based on elongation and tendon overlap. It is hypothesized that different patients will benefit from different treatments instead of offering all the same treatment.TRIAL REGISTRATION: ClinicalTrials.gov, NCT03525964. Registered 16 May 2018.
KW - Achilles Tendon/diagnostic imaging
KW - Acute Disease
KW - Adult
KW - Aged
KW - Algorithms
KW - Case-Control Studies
KW - Conservative Treatment
KW - Denmark/epidemiology
KW - Gait Analysis/methods
KW - Heel/physiopathology
KW - Humans
KW - Intention to Treat Analysis
KW - Lysholm Knee Score
KW - Magnetic Resonance Imaging/methods
KW - Middle Aged
KW - Recovery of Function
KW - Rupture/diagnostic imaging
KW - Tendon Injuries/physiopathology
KW - Treatment Outcome
KW - Ultrasonography/methods
U2 - 10.1186/s13063-020-04332-z
DO - 10.1186/s13063-020-04332-z
M3 - Journal article
C2 - 32398120
VL - 21
JO - Trials
JF - Trials
SN - 1745-6215
M1 - 399
ER -
ID: 260055633